Sentences with phrase «on drugs research»

[145] National Indigenous Drug and Alcohol Committee, An economic analysis for Aboriginal and Torres Strait Islander offenders - prison vs residential treatment, Australian National Council on Drugs research paper no. 24, 2012, p xi.

In fact, if you believe Ackman's math, Valeant goes from one of the industry's stingiest companies when it comes to R&D, as critics contend, to one of the biggest spenders on drug research.

Not exact matches

Traditional drug giants have caught on to the not - so - dirty little secret that outsourcing drug research (and in - licensing) may be a more effective strategy than trying to create groundbreaking new molecules within the confines of a single lab.

The advantage of Zymeworks» strategy is that licensing platforms to big pharma entitles it to a combination of cash up front, milestone payments as the clients» research proceeds and potential royalties once one of the drugs developed on the platform reaches the market.

Advances in molecular biology and bioinformatics have led to an explosion of research on the causes of hearing loss and how to fix it with drugs or gene therapy.

Walmsley, who took over a year ago, is focusing on rebuilding GSK's drug pipeline by overhauling research and appointing heavyweight outsiders, such as veteran Roche scientist Hal Barron.

«The tools they gain and the opportunities they earn permanently break the cycles of drug - use, incarceration, and poverty for them and their families, for life,» O'Donnell said in a statement to Business Insider, pointing us to some research outlined on The Doe Fund's website:

Cummings: The research has shown, first of all, that whenever [Congress] shine a light on prescription - drug companies with regard to price hikes automatically they have a tendency to slow down the rate of price hikes.

The same outside adviser, who was unidentified in Tuesday's release, advised that a package of assistance programs to patients would: «force reporters to focus on the byzantine nature of drug pricing and health care and ensure the patient message gets out... specifically tie profits from Daraprim to the research and development of a new and more effective treatment for Daraprim patients.

Both in practice and in his research, the Mexico City native is focused on improving the world, whether through studies on social enterprise and microfinance or a TED talk on brand management and Mexican drug cartels that accumulated more than 1 million views.

According to a study published last year by the National Bureau of Economic Research, American consumers are spending an estimated extra $ 44 billion a year on brand - name drugs, health care items and pantry goods.

While government science and tech funding is focused on basic research, corporate R&D mostly aims to bring new, slightly - improved products (like the upgraded iPhone or marginally - better cholesterol drug) to market.

On the other hand, Biogen has its roots in a Cambridge start - up founded in 1978 by MIT and Harvard scientists working in small, separate labs on then - radical theories, pursuing research dead ends and racking up debt until blockbuster drugs for treating leukemia, MS, and non-Hodgkin's lymphoma brought major commercial succesOn the other hand, Biogen has its roots in a Cambridge start - up founded in 1978 by MIT and Harvard scientists working in small, separate labs on then - radical theories, pursuing research dead ends and racking up debt until blockbuster drugs for treating leukemia, MS, and non-Hodgkin's lymphoma brought major commercial succeson then - radical theories, pursuing research dead ends and racking up debt until blockbuster drugs for treating leukemia, MS, and non-Hodgkin's lymphoma brought major commercial success.

The institute, which includes over 40 laboratories and more than 300 researchers, said the research would focus on modifying a patient's own immune system T - cells to target a tumor, studying ways to boost patient response to current immunotherapy drugs.

In January 2017, SiteOne announced the closing of a research and development agreement with Amgen, a collaboration focused on combining SiteOne's experienced drug discovery team and portfolio of novel Naᵥ1.7 inhibitors with Amgen's neuroscience capabilities.

The Belgian group specialises in the research of novel drugs based on nano - bodies found in the immune systems of llamas and alpacas, for which it partners with several of the world's largest pharmaceutical companies.

This may seem contradictory, as the U.S. biopharmaceutical industry is the world's leader in drug research and has a total economic impact of $ 790 billion a year on the U.S. economy.

But a funny thing happened as the company took on projects (research on the deaf as well as on drug use and AIDS) further and further afield from its initial market.

But research violations — including inappropriate drug testing on children and falsified data — forced the school to repay a National Institute of Mental Health grant for a whopping $ 3.1 million.

Eagle's Sassouni pointed out that since the big drug companies are losing billions of dollars every year to generic versions and have little to spend on their own research and development, they are looking to buy smaller biotechnology companies that are developing their own products.

Even if some of the money that Valeant has spent on acquisitions has made its way into funding new drug research, it's probably a small faction.

Count all the money Valeant has spent on acquisitions as drug research, and suddenly it has spent 200 % of its revenue over the past five years on R&D.

PERTH - based Medi - tech Research Limited may be on the brink of a major advance in cancer therapy with its hyaluronic acid technology for the delivery of anti-cancer drugs.

Previous research that focused on adolescents» use of the drug in the wake of medical marijuana laws didn't find an increase in that age group, she said.

China's regulatory authorities have also recognised these demographics, and are keen on overhauling the drug approval mechanism and accelerating the research and development process for innovative drugs.

The company focuses on cancer drug research and has a platform for so - called «real - world» data, which can be used to assess the economic value of medicines and is sought after by drug makers looking to justify their prices to health insurers.

«We're not going to ration or restrict this drug in any way that would negatively impact these patients,» Khot says, adding that he hopes to do more research on how the decreased use of both drugs has affected patients.

«This isn't like a cholesterol medicine; these are really, very specialized drugs,» says Khot, who is lead author on the peer - reviewed research letter.

Valeant provided details of its relationship with Philidor after influential short - seller Citron Research on Oct. 21 accused the drugmaker of using Philidor to inflate revenue from its medicines by stockpiling drugs at the pharmacy.

He has served on National Cancer Institute (NCI) Steering Committees for Genitourinary Cancer (GUSC) and Investigational Drugs (IDSC)- Immunotherapy Task Force, and is a senior editor for Cancer Immunology Research.

Andrew's primary responsibility at RA Capital is to evaluate public and private investments in companies developing drugs, medical devices, diagnostics, and research tools, with a focus on new company formation.

His doctoral research focused on the regulation of the ERK / MAPK pathway by adenylyl cyclases during long - term memory formation and sensitization to drugs of abuse.

SOUTH SAN FRANCISCO, Calif. — February 5, 2018 — FLX Bio, Inc., a biopharmaceutical company focused on the discovery and development of oral small molecule drugs to activate the immune system against cancer, today announced the appointment of senior pharmaceutical research and development executive Michael F. Giordano, M.D., to its Board of Directors.

These companies tend to have more dependable streams of revenue and a more diversified «pipeline» of drugs in the research and development stages, making them less dependent on make - or - break drug trials and their shares less volatile.

Major pharmaceuticals firms also engage in research and development, but tend to focus more on manufacturing and marketing an existing portfolio of drugs than the typical biotech firm.

Celgene also has in excess of 30 collaborations that help reduce what it spends on internal research and development while ensuring its cash only heads toward the most promising experimental drugs.

Prior to joining the APF Canada, Joelle was a Junior Research Associate with the United Nations Office on Drugs and Crime in Myanmar, and a Graduate Research Fellow with the Centre for International Governance Innovation

This increased survival rate places a high value on immunotherapy drugs and the companies that research and produce them.

But what Sequoia married itself to was an offshore drug company that borrowed heavily to buy other drug companies, cut costs and research, then raised prices on many older drugs to astronomical heights.

That's because it costs on average, $ 1.2 billion dollars to bring a new drug to market — from the time it is a twinkle in a scientist's eye, through a decade or more of lab research, to clinical trials and finally FDA approval.

That may come as a surprise amid hand - wringing about the spiraling cost of health care, but two new studies, one from research company IMS Health and one from pharmacy benefit manager Express Scripts, show that the amount of money Americans spend on prescription drugs went down in 2012 for the first time in decades.

-RRB- are contracted out by large drug companies to efficiently and comprehensively perform research on their products and help them bring the drug to market.

Esperion Therapeutics Inc (NASDAQ: ESPR) is finishing research on its bemepedoic acid for lipid management, and while the Street expects success, the drug's potential is weighted by a dearth of interested buyers.

Pharmaceutical Research and Manufacturers of America, or PhRMA, the trade group that advocates for drug companies, spent almost $ 10 million on lobbying in the first quarter of 2018, according to the Center for Responsive Politics.

MaRS Innovation (MI) and the Centre for Drug Research and Development (CDRD) are pleased to announce that they have entered into an agreement to collaborate on projects of mutual interest with a goal to advance and commercialize early - stage health - related discoveries.

That cash doesn't include the money PhRMA's spending on the ongoing «Go Boldly» campaign, a series of TV, print and radio ads designed to polish the drug industry's image by reminding the public that drug companies do world - class research that brings disease cures to market to save lives.

Perhaps so many of these new drugs fail to have an effect because the basic research on which their development was based isn't valid.

Looking at sixty - seven recent drug discovery projects based on preclinical cancer biology research, they found that in more than 75 percent of cases the published data did not match up with their in - house attempts to replicate.

(i) a woman's right to choose; (ii) teaching evolution in school; (iii) medical immunization of teen girls against HPV; (iv) assisted suicide; (v) gay marriage; (vi) my right to view art and theatre deemed «offensive,» «blasphemous» or «obscene» by theists (vii) basic $ ex education for older school children; (viii) treating drug abuse as principally a medical issue; (xi) population control; (x) buying alcohol on a Sunday; (xi) use of condoms and other contraceptives (xii) stem cell research.

This makes me happy: Research on ribosomes by Noller and others has led to the development of novel antibiotics that hold promise for use against drug - resistant bacteria.